Accolade (ACCD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Accolade Revenue Highlights


Latest Revenue (Y)

$414.29M

Latest Revenue (Q)

$106.36M

Main Segment (Y)

Access fees

Accolade Revenue by Period


Accolade Revenue by Year

DateRevenueChange
2024-02-29$414.29M14.09%
2023-02-28$363.14M17.13%
2022-02-28$310.02M81.98%
2021-02-28$170.36M28.57%
2020-02-29$132.51M39.76%
2019-02-28$94.81M23.41%
2018-02-28$76.83M-

Accolade generated $414.29M in revenue during NA 2024, up 14.09% compared to the previous quarter, and up 436.97% compared to the same period a year ago.

Accolade Revenue by Quarter

DateRevenueChange
2024-08-31$106.36M-3.72%
2024-05-31$110.47M-11.51%
2024-02-29$124.83M25.62%
2023-11-30$99.37M2.59%
2023-08-31$96.86M3.90%
2023-05-31$93.23M-5.86%
2023-02-28$99.03M8.88%
2022-11-30$90.95M3.77%
2022-08-31$87.64M2.47%
2022-05-31$85.53M-8.78%
2022-02-28$93.76M12.35%
2021-11-30$83.45M13.87%
2021-08-31$73.29M23.12%
2021-05-31$59.53M0.50%
2021-02-28$59.23M54.07%
2020-11-30$38.44M4.50%
2020-08-31$36.79M2.49%
2020-05-31$35.89M-19.23%
2020-02-29$44.44M49.88%
2019-11-30$29.65M0.00%
2019-08-31$29.65M3.09%
2019-05-31$28.76M-18.03%
2019-02-28$35.09M66.81%
2018-11-30$21.04M-

Accolade generated $106.36M in revenue during Q2 2025, up -3.72% compared to the previous quarter, and up 114.09% compared to the same period a year ago.

Accolade Revenue Breakdown


Accolade Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceFeb 24Feb 23Feb 22
Health Care, Patient Service$113.80M--
Access fees$300.49M$284.14M-
Utilization-based fees-$79.00M-
Utilization-Based Fees--$45.41M
Access Fees--$264.61M

Accolade's latest annual revenue breakdown by segment (product or service), as of Feb 24: Access fees (72.53%), and Health Care, Patient Service (27.47%).

Quarterly Revenue by Product

Product/ServiceAug 24May 24Feb 24Nov 23Feb 23Nov 22Aug 22May 22
Access Fees$72.65M$76.96M$70.82M$67.88M$68.13M---
Health Care, Patient Service$33.71M$33.51M$85.25M$28.55M----
Utilization-based fees----$20.85M$20.98M--
Access fees----$78.18M$69.97M--
Utilization-Based Fees------$19.77M$17.40M

Accolade's latest quarterly revenue breakdown by segment (product or service), as of Aug 24: Access Fees (68.30%), and Health Care, Patient Service (31.70%).

Accolade Revenue Breakdown by Country

Quarterly Revenue by Country

CountryFeb 23Nov 22Aug 22May 22
Utilization-based fees$20.85M$20.98M--
Access fees$78.18M$69.97M--
Utilization-Based Fees--$19.77M$17.40M
Access Fees--$67.88M$68.13M

Accolade's latest quarterly revenue breakdown by geography, as of Feb 23: Access fees (78.95%), and Utilization-based fees (21.05%).

Accolade Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
EVHEvolent Health$1.96B$647.14M
PRVAPrivia Health Group$1.66B$422.33M
PINCPremier$1.35B$342.60M
CMAXCareMax$751.10M$198.63M
ACCDAccolade$414.29M$106.36M
PHRPhreesia$356.30M$102.11M
CERTCertara$354.34M$93.31M
CPSITruBridge$326.65M$82.71M
HCATHealth Catalyst$295.94M$74.72M
HSTMHealthStream$279.06M$73.09M
DHDefinitive Healthcare$251.41M$63.70M
NRCNational Research$148.58M$35.31M

ACCD Revenue FAQ


Accolade's yearly revenue for 2024 was $414.29M, representing an increase of 14.09% compared to 2023. The company's yearly revenue for 2023 was $363.14M, representing an increase of 17.13% compared to 2022. ACCD's yearly revenue for 2022 was $310.02M, representing an increase of 81.98% compared to 2021.

Accolade's quarterly revenue for Q2 2025 was $106.36M, a -3.72% decrease from the previous quarter (Q1 2025), and a 9.80% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $110.47M, a -11.51% decrease from the previous quarter (Q4 2024), and a 18.49% increase year-over-year (Q1 2024). ACCD's quarterly revenue for Q4 2024 was $124.83M, a 25.62% increase from the previous quarter (Q3 2024), and a 26.06% increase year-over-year (Q4 2023).

Accolade's revenue growth rate for the last 3 years (2022-2024) was 33.63%, and for the last 5 years (2020-2024) was 212.66%.

Accolade's revenue streams in b 24 are Health Care, Patient Service, and Access fees. Health Care, Patient Service generated $113.8M in revenue, accounting 27.47% of the company's total revenue Access fees generated $300.49M in revenue, accounting 72.53% of the company's total revenue, up 5.75% year-over-year.

For the fiscal year ending Feb 24, the largest source of revenue of Accolade was Access fees. This segment made a revenue of $300.49M, representing 72.53% of the company's total revenue.